What's more, quite a few effectively established adverse prognostic markers, which include U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, dropped their unfavorable outcome in clients handled with VO. The only real element that remained predictive of a shorter progression-free survival During this cohort of individuals was TP53 aberrations.112 Fi